Blog
RSS FeedPosted by Michael Wonder on 03 Dec 2024
HTA Policy and Methods Review update
3 December 2024 - The Minister for Health and Aged Care, the Hon Mark Butler MP has announced the Implementation Advisory ...
Posted by Michael Wonder on 01 Dec 2024
Update on the March 2025 meeting
28 November 2024 - As announced by the Minister on 6 November 2024, to process the unprecedented number of submissions for ...
Posted by Michael Wonder on 01 Dec 2024
Changes to the PBS listings for Opdualag and Vyxeos
1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...
Posted by Michael Wonder on 01 Dec 2024
Schedule of Pharmaceutical Benefits - 1 December 2024
1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Agenda for the March 2025 PBAC meeting (version 1)
28 November 2024 - The agenda for the March 2025 PBAC meeting is now available. ...
Posted by Michael Wonder on 01 Dec 2024
Life changing endometriosis treatment now cheaper
1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...
Posted by Michael Wonder on 01 Dec 2024
Voters clamour for affordable health in election lead-up
30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...
Posted by Michael Wonder on 01 Dec 2024
DUSC utilisation analysis public release documents (June 2024) update
22 November 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 29 Nov 2024
Update from the PBAC (November 2024)
28 November 2024 - An update from the Chair and Deputy Chair of the PBAC is now available. ...
Posted by Michael Wonder on 27 Nov 2024
Australians benefit from new and expanded medicines on the PBS
20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...
Posted by Michael Wonder on 17 Nov 2024
Evidence of clinical benefit of cancer medicines considered for funding in Australia
14 November 2024 - The objective was to describe the type of evidence and the clinical benefit of cancer medicines ...
Posted by Michael Wonder on 16 Nov 2024
Outcome statement - October 2024 DUSC meeting
15 November 2024 - The outcome statement from the October 2024 DUSC meeting is now available. ...
Posted by Michael Wonder on 15 Nov 2024
Public Summary Documents (first time decisions not to recommend and deferrals) - July 2024 PBAC meeting
15 November 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2024 PBAC ...
Posted by Michael Wonder on 11 Nov 2024
World leading approach to protect babies from RSV
10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...
Posted by Michael Wonder on 11 Nov 2024
Pharmas allege Government communication breakdown in medicine deferral crisis
10 November 2024 - Labor has failed to plan for the consequences of delaying drug subsidies and left hundreds of ...